Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: A randomized comparative trial

Gynecologic and Obstetric Investigation

Volumn 74, Issue 2, 2012, Pages 151-156

  Cheewadhanaraks, Sopon ^a   Choksuchat, Chainarong ^a   Dhanaworavibul, Kriengsak ^a   Liabsuetrakul, Tippawan ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Depot medroxyprogesterone acetate; Endometriosis; Oral contraceptives; Pain

Indexed keywords

ETHINYLESTRADIOL; GESTODENE; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MASTALGIA; NAUSEA; OILY SKIN; OPEN STUDY; PAIN; PATIENT SATISFACTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 84866732851     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000337713     Document Type: Article

References (23)

1. Simoens S, Hummelshoj L, Dunselman G, Brandes I, Dirksen C, D'Hooghe T; Endo-Cost Consortium: Endometriosis cost assessment (the EndoCost study): a cost-of-ill-ness study protocol. Gynecol Obstet Invest 2011;71: 170-176.
2. Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N: Low-doseoralcont raceptive pill for dysmenorrhea associated with en-dometriosis: a placebo-controlled, doubleblind, randomized trial. Fertil Steril 2008;90:1583-1588.
3. Vercellini P, Frontino G, De Giorgi O, Pie-tropaolo G, Pasin R, Crosignani PG: Continuous use of an oral contraceptive for endo-metriosis- associated recurrent dysmenor-rhea that does not respond to a cyclic pill regimen. Fertil Steril 2003;80: 560-563.
4. Sesti F, Pietropolli A, Capozzolo T, Broccoli P, Pierangeli S, Bollea MR, et al: Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for en-dometriosis stage III-IV. A randomized comparative tria l. Fertil Steril 2007;88:1541-1547.
5. Seracchioli R, Mabrouk M, Frascà C, Manuzzi L, Savelli L, Venturoli S: Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril 2010;94: 464-471.
6. Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG: Endometri-osis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008;22:275-306.
7. Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG: Depot me-droxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis. Am J Obstet Gynecol 1996;175: 396-401.
8. Arowojolu AO: Treatment of endometriosis with depot medroxyprogesterone acetate: a preliminary experience. Afr J Med Med Sci 2000;29:55-58.
9. Walch K, Unfried G, Huber J, Kurz C, van Trotsenburg M, Pernicka E, et al: Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis-a pilot study. Contraception 2009;79: 29-34.
10. Cheewadhanaraks S, Peeyananjarassri K, Choksuchat C, Dhanaworavibul K, Choobun T, Bunyapipat S: Interval of injections of intramuscular depot medroxyprogesterone acetate in the long-term treatment of endo-metriosis- associated pain: a randomized comparative trial. Gynecol Obstet Invest 2009;68:116-121.
11. Wong AY, Tang LC, Chin RK: Levonor-gestrel-releasing intrauterine system (Mire-na) and depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomized controlled trial. Aust NZ J Obstet Gynaecol 2010;50: 273-279.
12. Crosignani PG, Luciano A, Ray A, Bergqvist A: Subcutaneous depot medroxyprogester-one acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 2006;21: 248-256.
13. Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A: Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril 2006;85: 314-325.
14. Biberoglu KO, Behrman SJ: Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gy necol 1981;139: 645-654.
15. Vercellini P, Cortesi I, Crosignani PG: Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril 1997; 68: 393–401.
16. Vercellini P, Somigliana E, Viganò P, De Matteis S, Barbara G, Fedele L: Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online 2010; 21: 259–265.
17. Meier C, Brauchli YB, Jick SS, Kraenzlin ME, Meier CR: Use of depot medroxyprogesterone acetate and fracture risk. J Clin Endocrinol Metab 2010; 95: 4909–4916.
18. Meresman GF, Augé L, Barañao RI, Lombardi E, Tesone M, Sueldo C: Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 2002; 77: 1141–1147.
19. Maia H Jr, Casoy J, Correia T, Freitas LA, Pimentel K, Athayde C: The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis. Gynecol Endocrinol 2008; 24: 123– 128.
20. Machado RB, Fabrini P, Cruz AM, Maia E, da Cunha Bastos A: Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg). Contraception 2004; 70: 365–370.
21. Muzii L, Maneschi F, Marana R, Porpora MG, Zupi E, Bellati F, et al: Oral estroprogestins after laparoscopic surgery to excise endometriomas: continuous or cyclic administration? Results of a multicenter randomized study. J Minim Invasive Gynecol 2011; 18: 173–178.